Idea Award

The purpose of the Idea Award is to stimulate the development of high-quality, innovative cancer research projects that will move forward to extramurally-funded grant awards. Idea awards provide early funding support for high-risk, high-payoff research for which external grants are difficult to obtain.

Purpose and Overview | Eligibility | Evaluation | Timelines

Idea Award Application

Applications are not being accepted at this time.

Purpose and Overview

MUSC Hollings Cancer Center leadership anticipates distributing awards of up to $50,000 for one year without the option to renew. Sources of funding for the award include the Hollings Cancer Center Support Grant (P30 CA138313), fundraising from the LOWVELO bike ride, and other Hollings philanthropy/foundation accounts.

Awardees are required to submit a timeline for a National Cancer Institute R01 or equivalent grant submission. In addition, a final progress report is required upon project completion, including an outline of project results and grant applications submitted and/or planned for submission. Any no-cost extensions will require prior approval. Principal investigators (PIs) are expected to seek regulatory (e.g., IACUC, IRB, etc.) approvals within three months of award decision. Please note that the funding cannot be released until all applicable human and animal subject protocols have been approved and copies have been sent to Brett Bechtol (bechtolb@musc.edu).

Eligibility

  • Proposed research must be cancer-relevant.
  • All MUSC faculty members are eligible to apply. Priority will be give to junior investigators.
  • Research can only take place, and expenditures incurred, at MUSC.
  • All awarded PIs and co-investigators are encouraged to participate as a registered rider in the annual LOWVELO bike ride event.

Evaluation

Each full application will be assigned to both internal and external reviewers who have substantial expertise in cancer research and in reviewing grants.

Review criteria include:

  • Standard NIH criteria (significance, innovation, approach, and investigative team);
  • Likelihood that preliminary results will lead to external, peer-reviewed funding;
  • Participation in Hollings Cancer Center programs (e.g., attend program meetings, participate in grant review panels, participate in annual research symposia, etc.);
  • The Future Funding Plan (see instructions) must describe how the funds will provide data that is critical to future extramural grant application(s);
  • When appropriate, describe the likelihood of the research to ultimately produce intellectual property, such as patents.

Applicants are strongly encouraged to consult a biostatistician when developing the research design and methods of their proposals (Dr. Hong Li [liho@musc.edu], Interim Director, Biostatistics Shared Resource).

Timelines

Full applications are due by 5 p.m. on Monday, March 8, 2021. Please email one PDF file of the application to Brett Bechtol (bechtolb@musc.edu). After peer review, notifications of award will be made, and the start date will be dependent on the status of human and animal studies protocol approvals. Applicants receiving a score just outside of the funding range will be notified with the possibility of resubmitting their application for a subsequent RFA cycle.